A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 1,643,776 shares of GILD stock, worth $150 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
1,643,776
Previous 1,647,773 0.24%
Holding current value
$150 Million
Previous $113 Million 21.87%
% of portfolio
0.32%
Previous 0.27%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$66.59 - $83.99 $266,160 - $335,708
-3,997 Reduced 0.24%
1,643,776 $138 Million
Q2 2024

Aug 08, 2024

SELL
$63.15 - $72.88 $9.2 Million - $10.6 Million
-145,642 Reduced 8.12%
1,647,773 $113 Million
Q1 2024

May 10, 2024

SELL
$71.58 - $87.29 $7.86 Million - $9.58 Million
-109,790 Reduced 5.77%
1,793,415 $131 Million
Q4 2023

Feb 09, 2024

SELL
$73.27 - $83.09 $6.3 Million - $7.14 Million
-85,990 Reduced 4.32%
1,903,205 $154 Million
Q3 2023

Nov 09, 2023

SELL
$73.94 - $80.67 $10.9 Million - $11.9 Million
-147,662 Reduced 6.91%
1,989,195 $149 Million
Q2 2023

Aug 08, 2023

BUY
$76.01 - $86.7 $19.9 Million - $22.7 Million
262,304 Added 13.99%
2,136,857 $165 Million
Q1 2023

May 10, 2023

BUY
$77.31 - $88.08 $5.55 Million - $6.32 Million
71,739 Added 3.98%
1,874,553 $156 Million
Q4 2022

Feb 10, 2023

SELL
$62.32 - $89.47 $2.45 Million - $3.51 Million
-39,263 Reduced 2.13%
1,802,814 $155 Million
Q3 2022

Nov 10, 2022

SELL
$59.54 - $68.01 $4.27 Million - $4.88 Million
-71,780 Reduced 3.75%
1,842,077 $114 Million
Q2 2022

Aug 09, 2022

BUY
$57.72 - $65.01 $7.98 Million - $8.99 Million
138,333 Added 7.79%
1,913,857 $118 Million
Q1 2022

May 12, 2022

BUY
$57.92 - $72.58 $929,847 - $1.17 Million
16,054 Added 0.91%
1,775,524 $106 Million
Q4 2021

Feb 09, 2022

BUY
$64.88 - $73.64 $1.97 Million - $2.23 Million
30,303 Added 1.75%
1,759,470 $128 Million
Q3 2021

Nov 12, 2021

BUY
$67.69 - $73.03 $15.5 Million - $16.7 Million
229,268 Added 15.29%
1,729,167 $121 Million
Q2 2021

Aug 12, 2021

SELL
$63.47 - $69.35 $1.17 Million - $1.28 Million
-18,449 Reduced 1.22%
1,499,899 $103 Million
Q1 2021

May 12, 2021

SELL
$60.0 - $68.46 $15.1 Million - $17.2 Million
-251,279 Reduced 14.2%
1,518,348 $95.6 Million
Q4 2020

Feb 12, 2021

BUY
$56.65 - $64.55 $6.65 Million - $7.58 Million
117,392 Added 7.11%
1,769,627 $103 Million
Q3 2020

Nov 12, 2020

BUY
$62.1 - $78.08 $2.74 Million - $3.45 Million
44,181 Added 2.75%
1,652,235 $104 Million
Q2 2020

Sep 11, 2020

BUY
$72.34 - $84.0 $20.3 Million - $23.6 Million
280,850 Added 21.16%
1,608,054 $124 Million
Q2 2020

Aug 13, 2020

SELL
$72.34 - $84.0 $4.75 Million - $5.51 Million
-65,611 Reduced 4.71%
1,327,204 $124 Million
Q1 2020

May 13, 2020

BUY
$62.63 - $80.22 $2.35 Million - $3.01 Million
37,522 Added 2.77%
1,392,815 $104 Million
Q4 2019

Feb 14, 2020

BUY
$61.62 - $67.78 $6.81 Million - $7.49 Million
110,560 Added 8.88%
1,355,293 $88.1 Million
Q3 2019

Nov 12, 2019

BUY
$62.51 - $69.0 $11.2 Million - $12.3 Million
178,519 Added 16.74%
1,244,733 $78.4 Million
Q2 2019

Aug 07, 2019

BUY
$61.87 - $69.38 $1.22 Million - $1.37 Million
19,737 Added 1.89%
1,066,214 $71.5 Million
Q1 2019

May 13, 2019

SELL
$62.53 - $70.05 $955,208 - $1.07 Million
-15,276 Reduced 1.44%
1,046,477 $66.7 Million
Q4 2018

Feb 12, 2019

BUY
$60.54 - $79.0 $2.01 Million - $2.63 Million
33,259 Added 3.23%
1,061,753 $66.4 Million
Q3 2018

Nov 13, 2018

SELL
$71.28 - $78.92 $119 Million - $132 Million
-1,670,699 Reduced 61.9%
1,028,494 $79.4 Million
Q2 2018

Aug 10, 2018

BUY
$64.88 - $75.68 $1.14 Million - $1.33 Million
17,553 Added 0.65%
2,699,193 $191 Million
Q1 2018

May 11, 2018

SELL
$72.84 - $88.8 $4.01 Million - $4.89 Million
-55,096 Reduced 2.01%
2,681,640 $202 Million
Q4 2017

Feb 09, 2018

BUY
$71.15 - $83.52 $664,185 - $779,659
9,335 Added 0.34%
2,736,736 $196 Million
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $197 Million - $233 Million
2,727,401
2,727,401 $221 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $114B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Mitsubishi Ufj Trust & Banking Corp Portfolio

Follow Mitsubishi Ufj Trust & Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.